TOKU-E公司专注于体外抗生素生产技术，并快速成长为世界领先的超纯抗生素供应者，以低廉的价格提供最全面的超纯抗生素，其纯度大于99%，用于动物细胞培养、植物组织培养、微生物、抗真菌及诊断等科研领域，允许研究者提高抗生素浓度，并消除污染，降低对细胞的伤害，从而提高筛选效率；该公司还提供精细化学试剂，如超纯丙烯酰胺、无尘SDS、胍盐等，极大提高了实验的精确性和安全性，可满足生命科学研究领域各科研机构，标准化组织机构的高标准需求。

When our doors first opened in 1981, we were a chemical trading company in Tokyo, Japan called TOKUICHI, which means‘moral first’in Japanese. Having established a firm foundation, our company focused on manufacturing antibiotics through fermentation, then specialized in pharma and biotech research sectors. To reflect our growth into a leading global antibiotic manufacturer, we updated our name to TOKU-E. Though we have expanded our scope to better serve our customers, we still maintain our strong moral fiber.

TOKU-E has facilities in the US, China, Europe, and Singapore to serve you globally, and our network of worldwide distributors offers region-specific expertise. Our company is ISO 9001:2015 certified, for your regulatory peace of mind.

TOKU-E的主要产品包括：

（1）Cell Culture

Gene Selection Antibiotics

Contamination Control

Mycoplasma Detection & Elimination

（2）Cancer Research

Antitumor

Chemotherapeutics

Immunosuppressants

（3）Microbiology

Antimicrobials

Gene Selection Antibiotics

Beta-lactamase Inhibitors

Nitrocefin

Selective Agents

（4）Plant Biology

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Stemmera公司位于美国加州，主要生产干细胞相关产品，包括检测试剂盒、培养基、抗体、缓冲液，还包括用于干细胞研究的细胞系。

Stemmera Inc is a privately owned biotechnology company located in Bay Area, California that focus in developing innovative technology and application solution for stem cell research. Our products include kit, culture medium, reagents, antibodies, buffer and solution, cell lines that are convenient tools used in stem cell research.

Stemmera公司主要产品：

（1）Kit

Alkaline Phosphatase (AP) Detection Kit (Ready-to-use)-Blue

Alkaline Phosphatase (AP) Detection Kit (Ready-to-use)-Red

Human Fibroblast (hFIB) Reprogramming Kit

Human Blood Cell (hBLD) Reprogramming Kit

（2）Media

Human ESCs/iPSCs Serum-/ Feeder-Free Medium (hStemSFM)

Human ESCs/iPSCs Xeno-Free Medium (hStemXFM)

Human Fibroblast (hFIB) Reprogramming Medium

Human Blood Cell (hBLD) Reprogramming Medium

Fibroblast Growth Medium

（3）Buffer & Solutions

Non-Enzymatic Cell Dissociation Solution (1X)

Serum-Free Cryopreservation Solution for Human ESCs/iPSCs

0.2% Gelatin

0.1% Gelatin

Universal Cryopreservation Solution

Blood Cell Cryopreservation Solution (1x)

Cell Fixation Solution (4% Paraformaldehyde, PFA)

Cell Fixation Solution (10% Formalin)

Metaphase Arrest Solution (10 μg/ml, 10X)

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Allele Biotechnology位于美国圣地亚哥市，主要专注于对生物过程的机制进行探索，以开发生物医学及治疗相关的技术和产品。以各个物种的iPS细胞、人类cGMP iPS细胞及衍生的细胞为材料，Allele Biotechnology利用专利性的非整合细胞编辑方法，开发了出了细胞治疗和药物筛选的技术。Allele Biotechnology具有深厚的基因组修饰和细胞荧光报告因子的经验，为客户提供优异的细胞检测解决方案。Allele Biotechnology还提供荧光蛋白、高效荧光素酶底物、基因分型试剂盒、骆驼抗体等产品；此外还在RNA干扰领域尤其独特的专利。

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development.

Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating cellular reprogramming methods to develop cell therapy and enable drug discovery through the use of human and non-human primate iPS cells, cGMP-grade human iPS cells and their derivatives. With additional expertise in genome modification and unique cell-based fluorescence sensors/reporters, Allele provides advanced cell and assay development solutions. Allele also has developed a wide variety of advanced research tools including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies that have been validated for co-immunoprecipitation, histology, and flow cytometry. The Company has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.